STAT News in “Biden’s executive order would pause a Trump rule forbidding march-in rights to lower drug costs” reports: “In a little-noticed move, the Biden administration has hit the pause button on a rule that would prevent the federal government from using a controversial legal provision for combating the high prices of products developed with taxpayer dollars.”